Company
Sections
- About Us
- Downloads
- Case Studies
- Latest News
- Newsletters
- Events
- Press Area
- Testimonials
- Testimonial Video
- Lexacom ITN Video
About Us
Lexacom is the driving force behind the development of innovative and cost-effective digital dictation software in the UK.
The company (registered as Aprobrium Ltd), successfully wrote and launched the world’s first digital dictation platform in 1997 and has been at the cutting edge of technical innovation and development ever since.
Based in the English county of Oxfordshire, Lexacom has established itself as a leading supplier of digital dictation solutions to the healthcare, legal and finance sectors where the efficient handling and processing of information is vital.
To ensure its digital dictation products always meet the specific demands and requirements of its customers, Lexacom’s highly proficient programmers work on future product developments and enhancements in consultation with designers who constantly evaluate the specific workflow management requirements of its markets.
To that end, Lexacom’s latest software boasts a number of exclusive features that take advantage of the latest communications technologies and are completely unique in the digital dictation marketplace. Lexacom’s strong commitment to R&D ensures it retains its place at the forefront of dictation management – today and into the future.
Lexacom also prides itself on the strength of its customer service and is proud to employ a team of talented and dedicated personnel that ensure the smooth delivery of a complete and effective digital solution to all customers. Every member of the Lexacom team is fully trained and able to handle all customer enquiries with speed, efficiency and a personal attention to detail.
To meet the demands of its growing customer base across the world, Lexacom has just opened an office in Dubai that will oversee the growth and development of digital dictation technology in the Middle East region.
Newsletter
Sign up now to stay informed of new products and developments.